Loading articles...
Patients with Crohn's disease who experience a primary loss of response to treatment may be identifiable through novel endoscopic parameters. This technology offers the potential for earlier intervention and personalized treatment strategies.
Crohn's disease patients can experience a loss of response to therapy, requiring more intensive interventions. Identifying those at risk early using endoluminal parameters may allow for proactive treatment adjustments and improved outcomes.